SCHEMBL4210145

SCHEMBL4210145

COc1cc(NC(=O)OCc2ccccc2)c(OC)cc1N

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
AAK1 Q2M2I8 1/20 0.53
MEN1 O00255 2/20 0.51
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAOB P27338 2/20 0.50
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
ACHE P22303 1/20 0.49
TACR3 P29371 1/20 0.47
MGLL Q99685 1/20 0.47
PLAU P00749 1/20 0.46
POLB P06746 1/20 0.46
KDM1A O60341 1/20 0.45
MAOA P21397 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4202527 0.90 NPC1 (0.60) KMT2ANPC1RAB9AAAK1MEN1
SCHEMBL5223936 0.85 KMT2A (0.62) KMT2ANPC1RAB9AAAK1MEN1
SCHEMBL9524227 0.85 NPC1 (0.56) KMT2ANPC1RAB9AAAK1MEN1
SCHEMBL10163089 0.84 KMT2A (0.58) KMT2ANPC1RAB9AMEN1L3MBTL1
SCHEMBL11694836 0.82 TP53 (0.57) KMT2ANPC1RAB9AMEN1L3MBTL1
SCHEMBL27943694 0.82 MGLL (0.56) KMT2ANPC1RAB9AMEN1HDAC3
SCHEMBL11306171 0.82 MEN1 (0.66) KMT2AMEN1HDAC1L3MBTL1POLB
SCHEMBL9116458 0.81 RECQL (0.53) HDAC3HDAC1HDAC2L3MBTL1
SCHEMBL10489859 0.81 KDM4E (0.60) KMT2ANPC1RAB9AMEN1TACR3
SCHEMBL5783658 0.80 HTT (0.59) KMT2ANPC1RAB9AAAK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7488738-B2 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2009-02-10 US disclosed
EP-1228367-B1 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF ASUBIO PHARMA CO LTD (JP) 2007-09-26 EP disclosed
US-20060178401-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof DAIICHI ASUBIO PHARMA CO., LTD. 2006-08-10 US disclosed
CN-1264821-C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SUNTORY LTD (JP) 2006-07-19 CN disclosed
US-7067533-B2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof DAIICHI ASUBIO PHARMA CO., LTD. (JP) 2006-06-27 US disclosed
US-6998401-B2 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof SUNTORY LIMITED (JP) 2006-02-14 US disclosed
US-20050245574-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2005-11-03 US disclosed
CN-1198613-C Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical composition containing the same FIRST SUNTORY PHARMACEUTICAL L (JP) 2005-04-27 CN disclosed
EP-1045693-B1 AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTANTS DAIICHI SUNTORY PHARMA CO LTD (JP) 2004-06-30 EP disclosed
US-20040063748-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2004-04-01 US disclosed
CN-1449493-A Aminophenoxyacetamide derivatives and pharmaceutical compositions containing them SUNTORY LTD (JP) 2003-10-15 CN disclosed
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2003-07-24 US disclosed
US-6559146-B1 Neuroprotective effects by inducing calbindin D28Kd, one of Ca2+-binding proteins SUNTORY LIMITED (JP) 2003-05-06 US disclosed
CN-1287487-A Aminophenoxyacetic acid derivatives and pharmaceutical compositions containing them SUNTORY LTD (JP) 2001-03-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245574-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof CAMK2A, CAMK2B, SLC1A2 KMT2A 2011/4885NPC1 4389/4885RAB9A 2079/4885
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SCN10A, CAMK2A, CAMK2B KMT2A 2191/4885NPC1 3518/4885RAB9A 3105/4885
US-20040063748-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof FABP7, SLC1A2, CAMK2A KMT2A 2239/4885NPC1 4270/4885RAB9A 1698/4885
US-20060178401-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof NR0B1, NR0B2, NR4A1 KMT2A 1299/4885NPC1 2348/4885RAB9A 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.